Tech Company Financing Transactions

OPX Biotechnologies Funding Round

US Renewables Group, Altira Group and Braemar Energy Ventures invested in a $36.5 million Series C venture round for OPX Biotechnologies. The round closed on 7/7/2011.

Transaction Overview

Announced On
7/7/2011
Transaction Type
Venture Equity
Amount
$36,500,000
Round
Series C
Investors

US Renewables Group (Lead Investor) (Jonathan Koch)

Altira Group (James Newell)

Braemar Energy Ventures (William Lese)

DBL Investors

Mohr Davidow Ventures (Erik Straser)

XSeed Capital

Proceeds Purpose
The new investment will enable OPXBIO to accelerate development and commercialization of an industrial-scale process for producing its first renewable chemical, BioAcrylic.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2425 55th St. 100
Boulder, CO 80301
USA
Email Address
Not Recorded
Overview
OPX Biotechnologies, Inc. is a new company dedicated to enabling renewable fuels and chemicals that are economically and environmentally superior to petroleum-based products.
Profile
OPX Biotechnologies LinkedIn Company Profile
Social Media
OPX Biotechnologies Company Twitter Account
Company News
OPX Biotechnologies News
Facebook
OPX Biotechnologies on Facebook
YouTube
OPX Biotechnologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David MacLennan
  David MacLennan LinkedIn Profile  David MacLennan Twitter Account  David MacLennan News  David MacLennan on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/7/2011: Avedro venture capital transaction
Next: 7/7/2011: Finsphere venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary